Lecanemab Biosimilar - Research Grade

Kummer, N. et al. Anti-amyloid antibody effects on Aβ-42 protein aggregates profiled using nanospectroscopy. bioRxiv, 2025.07.17.665305;

Human

Amyloid Beta

5mg/ml

Human IgG1 Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects Amyloid Beta

Blue ice

Amyloid beta aggregates are central to the pathology of Alzheimer's disease and a primary target in neurodegeneration research. This recombinant anti-amyloid-beta monoclonal is an unconjugated, non-therapeutic analog of lecanemab, supplied for research use only (RUO). Manufactured to in vivo standards with low endotoxin, it is offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Applications include functional assays, protofibril- and aggregate-binding studies, reproducible controls, and in vivo models of amyloid pathology, providing the lot-to-lot consistency essential for reproducible neurodegeneration research at scale.

P05067

ICH3002

https://www.imgt.org/mAb-DB/